Cell isolation process involves separation of one or multiple cell types from the heterogeneous population of cells for biological, cell-based research, routine clinical diagnosis, and treatment. Increasing prevalence of cancer, rising government funding for cell-based research, and technological advancements are major drivers for the growth of cell isolation market. For instance, in August 2016, GE Healthcare entered into an agreement with STEMCELL Technologies Inc. to provide T-Cell reagents for commercial-scale cell therapy production. Furthermore, in July 2017, Bio-Rad Laboratories in collaboration with Illumina, Inc. launched Single-Cell Sequencing Solution. This solution provides researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6193
On the other hand, the high cost of cell isolation systems, complex cell behavior characteristics, and ethical issues related to embryonic stem cell isolation is likely to hamper the market growth during the forecast period.
- Beckman Coulter (Subsidiary of Danaher Corporation)
- Becton, Dickinson, and Company
- GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Miltenyi Biotec
- Pluriselect Life Science
- Stemcell Technologies Inc.
- Terumo Bct (A Subsidiary of Terumo Corporation)
- Bio-Rad Laboratories, Inc.
The cell isolation market is segmented on the basis of product, cell type, technique, application, and end-user.
On the basis of the product, the market is classified as consumables and instruments. The consumables are further classified as reagents, kits, media, and sera, beads, disposables. The instruments are segmented into centrifuges, flow cytometers, magnetic-activated cell separation, and filtration system. The magnetic-activated cell separator system is further classified into manual magnetic-activated cell separator systems and automated magnetic-activated cell separator systems.
On the basis of the application, the market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutics.
On the basis of the end-user, the market is segmented as research laboratories and institutes, hospitals and diagnostic laboratories, cell banks, biotechnology and biopharmaceutical companies.
On the basis of cell type, the market is segmented into human cells and animal cells. The human cells are further segmented into differentiated cells and stem cells.
The cell isolation market on the basis of the technique is segmented as centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation.
The American region is expected to dominate the cell isolation market, owing to the existing well-established healthcare system, increasing prevalence of cancer cases, increasing government funding in research, and technological advancements. According to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancer had been diagnosed in the US Furthermore, the increasing cancer care expenditure in the United States is likely to drive the market growth. For instance, in 2017, the US Department of Health and Human Services estimated 147.3 billion USD national expenditures for cancer care.
Europe is anticipated to hold the second position in the cell isolation market. It is expected that the government support towards research & development expenditure and rising prevalence chronic diseases such as cancer is likely to drive the European cell isolation market. According to the Cancer Research UK, in 2012, 14.1 million cases of cancer were diagnosed all over the world, and 8.2 million died due to cancer. It also projected that the number of cancer patients is expected to reach 23.6 million in 2030.
The Asia-Pacific cell isolation market consists of countries namely China, Japan, Republic of Korea, India, and Australia. The market growth is mainly driven by rapidly expanding biopharmaceutical industries in the region and rising government funding in life sciences sector. Moreover, countries like India and China have established research institutes promoting cell-based research which contributes to the market growth.
The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.
Browse Complete 154 Pages Premium Research Report Enabled with 224 Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/cell-isolation-market-6193
Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Treatment Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar